Sort by
Refine Your Search
-
team integrates innovative high-throughput sequencing technologies, bioinformatics approaches, and multi-scale models to elucidate RNA-mediated endothelial biology in the context of diabetes. In parallel
-
. As a successful candidate, you will: · You must have experience with flow cytometry, molecular biology techniques, cell culture, microscopy, tissue processing, immunohistochemistry
-
methyltransferases (PRMTs) and methylarginine reader proteins control key RNA processing events, including pre-mRNA splicing, alternative polyadenylation, and RNA modification, and how disruption of
-
Research experience that includes medical image processing, Artificial Intelligence (AI) algorithm development, and scientific writing. Gain clinical experience including training in radiation oncology
-
, ensuring accurate documentation and handling procedures. Maintain knowledge of specimen processing requirements, laboratory procedures, and applicable safety practices. Coordinate protocol-related
-
arginine methylation and methylarginine reader proteins regulate chromatin function, gene expression, RNA processing, and genome organization in normal and disease states. We employ a multidisciplinary
-
genomics, molecular biology, cell biology, immunology, and in vivo model systems. For more information about Dr. Zhaohui Gu’s lab, please visit: https://gu-lab.net and https://www.cityofhope.org
-
our ReCord Study ( https://record.umn.edu ). Qualifications Your qualifications should include: · Ph.D. degree in genetics, genetic epidemiology, biological sciences, or a related discipline is
-
. Expertise in using mouse models to study metabolic diseases is preferred. For a complete list of Publications please visit here: https://www.ncbi.nlm.nih.gov/myncbi/1J54E41I5YVku/bibliography
-
strategies. Through these efforts, we aim to accelerate the translation of molecular and clinical insights into tools that improve patient outcomes. More information about the lab can be found here: https